- Home
- SLGL vs DXST Comparison
SLGL vs DXST Comparison
Compare SLGL & DXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- DXST
- Stock Information
- Founded
- SLGL 1997
- DXST 2011
- Country
- SLGL Israel
- DXST China
- Employees
- SLGL N/A
- DXST N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- DXST
- Sector
- SLGL Health Care
- DXST
- Exchange
- SLGL Nasdaq
- DXST NYSE
- Market Cap
- SLGL 19.3M
- DXST 20.1M
- IPO Year
- SLGL 2018
- DXST 2025
- Fundamental
- Price
- SLGL $13.00
- DXST $1.25
- Analyst Decision
- SLGL Buy
- DXST
- Analyst Count
- SLGL 1
- DXST 0
- Target Price
- SLGL $40.00
- DXST N/A
- AVG Volume (30 Days)
- SLGL 13.9K
- DXST 26.6K
- Earning Date
- SLGL 08-15-2025
- DXST 01-01-0001
- Dividend Yield
- SLGL N/A
- DXST N/A
- EPS Growth
- SLGL N/A
- DXST 13.11
- EPS
- SLGL N/A
- DXST 0.14
- Revenue
- SLGL $12,103,000.00
- DXST $11,542,292.00
- Revenue This Year
- SLGL N/A
- DXST N/A
- Revenue Next Year
- SLGL $31.17
- DXST N/A
- P/E Ratio
- SLGL N/A
- DXST $8.93
- Revenue Growth
- SLGL 603.66
- DXST 22.18
- 52 Week Low
- SLGL $3.34
- DXST $0.85
- 52 Week High
- SLGL $16.50
- DXST $5.74
- Technical
- Relative Strength Index (RSI)
- SLGL 87.12
- DXST N/A
- Support Level
- SLGL $10.95
- DXST N/A
- Resistance Level
- SLGL $12.90
- DXST N/A
- Average True Range (ATR)
- SLGL 1.12
- DXST 0.00
- MACD
- SLGL 0.40
- DXST 0.00
- Stochastic Oscillator
- SLGL 95.73
- DXST 0.00
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About DXST DECENT HOLDING INC
Decent Holding Inc through its subsidiary specializes in the provision of wastewater treatment by cleansing the industrial wastewater, ecological river restoration and river ecosystem management by enhancing the water quality, as well as microbial products used for pollutant removal and water quality enhancement. Its main services and products include (1) wastewater treatment, (2) river water quality management, and (3) microbial products for water quality enhancement and pollutant cleansing purposes. The company's focus is on research and development (R&D) to sharpen its innovation edge.